Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
153
datasets available to search
ShareScore release 0.9.0
Dataset results
153 results for “Signs and Symptoms”
Delphi survey on clinical signs and symptoms at primary health facilities
<p>Data from a Delphi survey conducted among 30 primary health care workers in Tanzania.</p> <p>The Delphi survey was based on a recent Delphi study among international experts on predictors of sepsis in children under five and included questions about each clinical element based on three domains: 1. Reliability of measurement, 2. Frequency of finding an abnormal value, and 3. Level of training required. Additionally, availability of instruments to measure vital signs and other challenges in collecting each element were evaluated. The answers were classified using a 5-point Likert scale: minimal, moderate, high, not applicable, I don’t know. The answer options for the availability of vital sign instruments were yes/no/I don’t know. We also collected data on the professional background and expertise of the participants. </p>
Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)
ClinicalTrials.gov study NCT04139798. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)
ClinicalTrials.gov study NCT04567329. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
ClinicalTrials.gov study NCT04795752. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
ClinicalTrials.gov study NCT04036292. IPD Sharing: NO. Countries: 1. Publications: 3.
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
ClinicalTrials.gov study NCT03333057. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
ClinicalTrials.gov study NCT00384930. IPD Sharing: Not stated. Countries: 1. Publications: 4.
To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing
ClinicalTrials.gov study NCT03105297. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
ClinicalTrials.gov study NCT04523129. IPD Sharing: NO. Countries: 1. Publications: 1.
Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
ClinicalTrials.gov study NCT03287635. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily
ClinicalTrials.gov study NCT00827242. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients
ClinicalTrials.gov study NCT01100437. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
ClinicalTrials.gov study NCT03292809. IPD Sharing: NO. Countries: 1. Publications: 2.
Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
ClinicalTrials.gov study NCT03636061. IPD Sharing: NO. Countries: 1. Publications: 4.
Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults
ClinicalTrials.gov study NCT03435614. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheum
ClinicalTrials.gov study NCT00175877. IPD Sharing: Not stated. Countries: 22. Publications: 6.
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)
ClinicalTrials.gov study NCT03452397. IPD Sharing: NO. Countries: 1. Publications: 1.
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004
ClinicalTrials.gov study NCT04523142. IPD Sharing: NO. Countries: 1. Publications: 1.
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
ClinicalTrials.gov study NCT00643279. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid
ClinicalTrials.gov study NCT00160641. IPD Sharing: Not stated. Countries: 13. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.